289 related articles for article (PubMed ID: 9642633)
1. Secondary central precocious puberty in a girl with McCune-Albright syndrome responds to treatment with GnRH analogue.
Schmidt H; Kiess W
J Pediatr Endocrinol Metab; 1998; 11(1):77-81. PubMed ID: 9642633
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
3. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
[TBL] [Abstract][Full Text] [Related]
4. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
[TBL] [Abstract][Full Text] [Related]
5. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
6. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
7. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Alves C; Silva SF
J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
[TBL] [Abstract][Full Text] [Related]
8. [Precocious puberty caused by McCune-Albright syndrome in a girl aged 6 years and 9 months].
Wikiera B; Wawro J; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):63-7. PubMed ID: 16704864
[TBL] [Abstract][Full Text] [Related]
9. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
Jung AJ; Soskin S; Paris F; Lipsker D
Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
[TBL] [Abstract][Full Text] [Related]
10. McCune Albright Syndrome (MCAS): a case series.
Rao S; Colaco MP; Desai MP
Indian Pediatr; 2003 Jan; 40(1):29-35. PubMed ID: 12554915
[TBL] [Abstract][Full Text] [Related]
11. [Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].
Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
Cesk Pediatr; 1994; 49(1):7-12. PubMed ID: 8124755
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
[TBL] [Abstract][Full Text] [Related]
13. McCune-Albright syndrome (MAS): early and extensive bone fibrous dysplasia involvement and "mistaken identity" oophorectomy.
Gucev Z; Tasic V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):837-42. PubMed ID: 21073128
[TBL] [Abstract][Full Text] [Related]
14. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
16. Treatment of central precocious puberty: lessons from a 15 years prospective trial. German Decapeptyl Study Group.
Partsch CJ; Heger S; Sippell WG
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():747-58. PubMed ID: 10969917
[TBL] [Abstract][Full Text] [Related]
17. McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.
Gryngarten M; Comar H; Arcari A; Boulgourdjian E; Escobar ME; Domené H
Arch Argent Pediatr; 2021 Oct; 119(5):e420-e427. PubMed ID: 34569743
[TBL] [Abstract][Full Text] [Related]
18. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
[TBL] [Abstract][Full Text] [Related]
19. Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-Albright syndrome: a preliminary report.
Syed FA; Chalew SA
J Pediatr Endocrinol Metab; 1999; 12(1):81-3. PubMed ID: 10392352
[TBL] [Abstract][Full Text] [Related]
20. Variations in pituitary-gonadal suppression during intranasal buserelin and intramuscular depot-triptorelin therapy for central precocious puberty. Belgian Study Group for Pediatric Endocrinology.
Heinrichs C; Craen M; Vanderschueren-Lodeweyckx M; Malvaux P; Fawe L; Bourguignon JP
Acta Paediatr; 1994 Jun; 83(6):627-33. PubMed ID: 7919761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
